Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ: LGND · Real-Time Price · USD
232.32
-9.47 (-3.92%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Ligand Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 4,655 | 3,721 | 2,025 | 1,245 | 1,128 | 2,581 | Upgrade
|
| Market Cap Growth | 138.68% | 83.80% | 62.59% | 10.35% | -56.28% | 61.40% | Upgrade
|
| Enterprise Value | 4,373 | 3,508 | 1,812 | 1,061 | 1,121 | 2,589 | Upgrade
|
| Last Close Price | 232.32 | 189.07 | 107.15 | 71.42 | 66.80 | 99.67 | Upgrade
|
| PE Ratio | 37.90 | 29.90 | - | 23.88 | - | 45.18 | Upgrade
|
| Forward PE | 40.83 | 35.20 | 53.58 | 35.07 | - | - | Upgrade
|
| PS Ratio | 17.36 | 13.88 | 12.11 | 9.48 | 5.75 | 10.69 | Upgrade
|
| PB Ratio | 4.52 | 3.66 | 2.44 | 1.78 | 1.89 | 3.14 | Upgrade
|
| P/TBV Ratio | 6.74 | 5.39 | 4.42 | 4.18 | 8.11 | 7.85 | Upgrade
|
| P/FCF Ratio | 95.19 | 76.09 | 21.26 | 27.04 | 8.99 | 36.86 | Upgrade
|
| P/OCF Ratio | 94.32 | 75.39 | 20.86 | 25.12 | 8.19 | 32.76 | Upgrade
|
| PEG Ratio | 2.17 | 2.42 | 3.57 | 2.34 | - | - | Upgrade
|
| EV/Sales Ratio | 16.31 | 13.08 | 10.84 | 8.08 | 5.71 | 10.72 | Upgrade
|
| EV/EBITDA Ratio | 54.01 | 43.32 | 31.11 | 22.90 | 27.11 | 22.09 | Upgrade
|
| EV/EBIT Ratio | 92.66 | 74.32 | 78.73 | 108.04 | 369.11 | 39.07 | Upgrade
|
| EV/FCF Ratio | 89.42 | 71.72 | 19.03 | 23.04 | 8.93 | 36.96 | Upgrade
|
| Debt / Equity Ratio | 0.44 | 0.44 | 0.01 | 0.01 | 0.15 | 0.40 | Upgrade
|
| Debt / EBITDA Ratio | 5.52 | 5.52 | 0.12 | 0.13 | 2.09 | 2.74 | Upgrade
|
| Debt / FCF Ratio | 9.23 | 9.23 | 0.08 | 0.13 | 0.70 | 4.63 | Upgrade
|
| Net Debt / Equity Ratio | -0.28 | -0.28 | -0.30 | -0.23 | -0.21 | -0.02 | Upgrade
|
| Net Debt / EBITDA Ratio | -3.48 | -3.48 | -4.27 | -3.54 | -3.00 | -0.14 | Upgrade
|
| Net Debt / FCF Ratio | -5.77 | -5.77 | -2.61 | -3.56 | -0.99 | -0.24 | Upgrade
|
| Asset Turnover | 0.21 | 0.21 | 0.19 | 0.17 | 0.19 | 0.18 | Upgrade
|
| Inventory Turnover | 8.24 | 8.24 | 1.71 | 1.88 | 4.38 | 3.50 | Upgrade
|
| Quick Ratio | 21.83 | 21.83 | 8.32 | 12.49 | 2.50 | 10.39 | Upgrade
|
| Current Ratio | 22.23 | 22.23 | 8.93 | 14.15 | 2.67 | 11.15 | Upgrade
|
| Return on Equity (ROE) | 13.47% | 13.47% | -0.53% | 8.29% | -0.74% | 9.98% | Upgrade
|
| Return on Assets (ROA) | 2.36% | 2.36% | 1.66% | 0.79% | 0.18% | 3.11% | Upgrade
|
| Return on Invested Capital (ROIC) | 5.02% | 5.61% | -6.59% | 1.64% | -0.07% | 8.50% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.10% | 3.10% | 2.50% | 1.30% | 0.50% | 5.30% | Upgrade
|
| Earnings Yield | 2.67% | 3.34% | -0.20% | 4.19% | -2.96% | 2.21% | Upgrade
|
| FCF Yield | 1.05% | 1.31% | 4.70% | 3.70% | 11.12% | 2.71% | Upgrade
|
| Buyback Yield / Dilution | -10.96% | -10.96% | -3.00% | -5.27% | 2.19% | -2.50% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.